https://wikem.org/w/index.php?action=history&feed=atom&title=Template%3AAcute_cystitis_antibiotics%2Fes Template:Acute cystitis antibiotics/es - Revision history 2026-04-18T01:13:09Z Revision history for this page on the wiki MediaWiki 1.38.2 https://wikem.org/w/index.php?title=Template:Acute_cystitis_antibiotics/es&diff=383286&oldid=prev Ostermayer: Created page with "'''Mujeres, Sin complicaciones''' *Nitrofurantoína ER 100mg BID x 5d, O *TMP/SMX DS (160/800mg) 1 tab BID x 3d (Mujeres) x7días (Hombres), O *Cefalexina 250mg QID x 5d, O *Ciprofloxacino 250mg BID x3d **Evitar el uso de fluorquinolona para el tratamiento de primera línea de infecciones del tracto urinario (ITU) sin complicaciones..." 2026-01-20T06:15:08Z <p>Created page with &quot;&#039;&#039;&#039;Mujeres, Sin complicaciones&#039;&#039;&#039; *<a href="/wiki/Special:MyLanguage/Nitrofurantoin" title="Special:MyLanguage/Nitrofurantoin">Nitrofurantoína</a> ER 100mg BID x 5d, O *<a href="/wiki/Special:MyLanguage/TMP/SMX" title="Special:MyLanguage/TMP/SMX">TMP/SMX</a> DS (160/800mg) 1 tab BID x 3d (Mujeres) x7días (Hombres), O *<a href="/wiki/Special:MyLanguage/Cephalexin" title="Special:MyLanguage/Cephalexin">Cefalexina</a> 250mg QID x 5d, O *<a href="/wiki/Special:MyLanguage/Ciprofloxacin" title="Special:MyLanguage/Ciprofloxacin">Ciprofloxacino</a> 250mg BID x3d **Evitar el uso de fluorquinolona para el tratamiento de primera línea de infecciones del tracto urinario (ITU) sin complicaciones...&quot;</p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 06:15, 20 January 2026</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l1">Line 1:</td> <td colspan="2" class="diff-lineno">Line 1:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>&lt;noinclude&gt;&lt;languages/&gt;&lt;/noinclude&gt;</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>&lt;noinclude&gt;&lt;languages/&gt;&lt;/noinclude&gt;</div></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">&lt;div lang</del>=<del style="font-weight: bold; text-decoration: none;">&quot;en&quot; dir</del>=<del style="font-weight: bold; text-decoration: none;">&quot;ltr&quot; class</del>=<del style="font-weight: bold; text-decoration: none;">&quot;mw-content-ltr&quot;&gt;</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins style="font-weight: bold; text-decoration: none;">Ambulatorio</ins>===</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del style="font-weight: bold; text-decoration: none;">Outpatient===</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">&lt;/div&gt;</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">&lt;div lang=&quot;en&quot; dir=&quot;ltr&quot; class=&quot;mw-content-ltr&quot;&gt;</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>'''<ins style="font-weight: bold; text-decoration: none;">Mujeres</ins>, <ins style="font-weight: bold; text-decoration: none;">Sin complicaciones</ins>'''</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>'''<del style="font-weight: bold; text-decoration: none;">Women</del>, <del style="font-weight: bold; text-decoration: none;">Uncomplicated</del>'''</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Nitrofurantoin|<ins style="font-weight: bold; text-decoration: none;">Nitrofurantoína</ins>]] ER 100mg BID x 5d, <ins style="font-weight: bold; text-decoration: none;">O</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Nitrofurantoin|<del style="font-weight: bold; text-decoration: none;">Nitrofurantoin</del>]] ER 100mg BID x 5d, <del style="font-weight: bold; text-decoration: none;">OR</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/TMP/SMX|TMP/SMX]] DS (160/800mg) 1 tab BID x 3d (<ins style="font-weight: bold; text-decoration: none;">Mujeres</ins>) <ins style="font-weight: bold; text-decoration: none;">x7días </ins>(<ins style="font-weight: bold; text-decoration: none;">Hombres</ins>), <ins style="font-weight: bold; text-decoration: none;">O</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/TMP/SMX|TMP/SMX]] DS (160/800mg) 1 tab BID x 3d (<del style="font-weight: bold; text-decoration: none;">Females</del>) <del style="font-weight: bold; text-decoration: none;">x7days </del>(<del style="font-weight: bold; text-decoration: none;">Males</del>), <del style="font-weight: bold; text-decoration: none;">OR</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Cephalexin|<ins style="font-weight: bold; text-decoration: none;">Cefalexina</ins>]] 250mg QID x 5d, <ins style="font-weight: bold; text-decoration: none;">O</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Cephalexin|<del style="font-weight: bold; text-decoration: none;">Cephalexin</del>]] 250mg QID x 5d, <del style="font-weight: bold; text-decoration: none;">OR</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Ciprofloxacin|<ins style="font-weight: bold; text-decoration: none;">Ciprofloxacino</ins>]] 250mg BID x3d</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Ciprofloxacin|<del style="font-weight: bold; text-decoration: none;">Ciprofloxacin</del>]] 250mg BID x3d</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>**<ins style="font-weight: bold; text-decoration: none;">Evitar el uso de fluorquinolona para el tratamiento de primera línea de infecciones del tracto urinario </ins>(<ins style="font-weight: bold; text-decoration: none;">ITU</ins>) <ins style="font-weight: bold; text-decoration: none;">sin complicaciones en mujeres</ins>.&lt;ref&gt;Choosing Wisely. American Urogynecologic Society. http://www.choosingwisely.org/societies/american-urogynecologic-society&lt;/ref&gt;</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>**<del style="font-weight: bold; text-decoration: none;">Avoid using fluoroquinolone for the first-line treatment of uncomplicated urinary tract infections </del>(<del style="font-weight: bold; text-decoration: none;">UTIs</del>) <del style="font-weight: bold; text-decoration: none;">in women</del>.&lt;ref&gt;Choosing Wisely. American Urogynecologic Society. http://www.choosingwisely.org/societies/american-urogynecologic-society&lt;/ref&gt;</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Fosfomycin|<ins style="font-weight: bold; text-decoration: none;">Fosfomicina</ins>]] 3 g <ins style="font-weight: bold; text-decoration: none;">VO una vez</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Fosfomycin|<del style="font-weight: bold; text-decoration: none;">Fosfomycin</del>]] 3 g <del style="font-weight: bold; text-decoration: none;">PO once</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>**<ins style="font-weight: bold; text-decoration: none;">Menor éxito clínico y microbiológico comparado con nitrofurantoína </ins>TID <ins style="font-weight: bold; text-decoration: none;">por </ins>5 <ins style="font-weight: bold; text-decoration: none;">días </ins>&lt;ref&gt;Huttner, A., Kowalczyk, A., Turjeman, A., Babich, T., Brossier, C., Eliakim-Raz, N., … Harbarth, S. (2018). Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial. JAMA: The Journal of the American Medical Association, 319(17), 1781–1789.&lt;/ref&gt;</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>**<del style="font-weight: bold; text-decoration: none;">Lower clinical and microbiologic success compared to nitrofurantoin </del>TID <del style="font-weight: bold; text-decoration: none;">for </del>5 <del style="font-weight: bold; text-decoration: none;">days </del>&lt;ref&gt;Huttner, A., Kowalczyk, A., Turjeman, A., Babich, T., Brossier, C., Eliakim-Raz, N., … Harbarth, S. (2018). Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial. JAMA: The Journal of the American Medical Association, 319(17), 1781–1789.&lt;/ref&gt;</div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>   </div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>   </div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>'''<del style="font-weight: bold; text-decoration: none;">Women</del>, <del style="font-weight: bold; text-decoration: none;">Complicated</del>'''</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>'''<ins style="font-weight: bold; text-decoration: none;">Mujeres</ins>, <ins style="font-weight: bold; text-decoration: none;">Complicadas</ins>'''</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Ciprofloxacin|<del style="font-weight: bold; text-decoration: none;">Ciprofloxacin</del>]] 500mg BID x10-14d, <del style="font-weight: bold; text-decoration: none;">OR</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Ciprofloxacin|<ins style="font-weight: bold; text-decoration: none;">Ciprofloxacino</ins>]] 500mg BID x10-14d, <ins style="font-weight: bold; text-decoration: none;">O</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Cefpodoxime|<del style="font-weight: bold; text-decoration: none;">Cefpodoxime</del>]] 200 mg BID x10-14d</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Cefpodoxime|<ins style="font-weight: bold; text-decoration: none;">Cefpodoxima</ins>]] 200 mg BID x10-14d</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">&lt;/div&gt;</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">&lt;div lang=&quot;en&quot; dir=&quot;ltr&quot; class=&quot;mw-content-ltr&quot;&gt;</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>'''<ins style="font-weight: bold; text-decoration: none;">Mujeres</ins>, <ins style="font-weight: bold; text-decoration: none;">Sospecha de </ins>[[Special:MyLanguage/Urethritis|<ins style="font-weight: bold; text-decoration: none;">Uretritis</ins>]]'''</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>'''<del style="font-weight: bold; text-decoration: none;">Women</del>, <del style="font-weight: bold; text-decoration: none;">Concern for </del>[[Special:MyLanguage/Urethritis|<del style="font-weight: bold; text-decoration: none;">Urethritis</del>]]'''</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Ceftriaxone|<ins style="font-weight: bold; text-decoration: none;">Ceftriaxona</ins>]] 250mg IM x1 <ins style="font-weight: bold; text-decoration: none;">Y </ins>[[Special:MyLanguage/azithromycin|<ins style="font-weight: bold; text-decoration: none;">azitromicina</ins>]] 1gm <ins style="font-weight: bold; text-decoration: none;">VO </ins>x1 <ins style="font-weight: bold; text-decoration: none;">Y </ins>[[Special:MyLanguage/nitrofurantoin|<ins style="font-weight: bold; text-decoration: none;">nitrofurantoína</ins>]] ER 100mg BID x5d, <ins style="font-weight: bold; text-decoration: none;">O</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Ceftriaxone|<del style="font-weight: bold; text-decoration: none;">Ceftriaxone</del>]] 250mg IM x1 <del style="font-weight: bold; text-decoration: none;">AND </del>[[Special:MyLanguage/azithromycin|<del style="font-weight: bold; text-decoration: none;">azithromycin</del>]] 1gm <del style="font-weight: bold; text-decoration: none;">PO </del>x1 <del style="font-weight: bold; text-decoration: none;">AND </del>[[Special:MyLanguage/nitrofurantoin|<del style="font-weight: bold; text-decoration: none;">nitrofurantoin</del>]] ER 100mg BID x5d, <del style="font-weight: bold; text-decoration: none;">OR</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Levofloxacin|<ins style="font-weight: bold; text-decoration: none;">Levofloxacino</ins>]] 500mg QD x 14d (<ins style="font-weight: bold; text-decoration: none;">cubre patógenos urinarios</ins>, [[Special:MyLanguage/GC|GC]], <ins style="font-weight: bold; text-decoration: none;">y </ins>[[Special:MyLanguage/chlamydia|<ins style="font-weight: bold; text-decoration: none;">clamidia</ins>]])</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Levofloxacin|<del style="font-weight: bold; text-decoration: none;">Levofloxacin</del>]] 500mg QD x 14d (<del style="font-weight: bold; text-decoration: none;">covers urinary pathogens</del>, [[Special:MyLanguage/GC|GC]], <del style="font-weight: bold; text-decoration: none;">and </del>[[Special:MyLanguage/chlamydia|<del style="font-weight: bold; text-decoration: none;">chlamydia</del>]])</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>**<ins style="font-weight: bold; text-decoration: none;">La resistencia de </ins>[[Special:MyLanguage/GC|GC]] <ins style="font-weight: bold; text-decoration: none;">a fluorquinolonas está aumentando</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>**[[Special:MyLanguage/GC|GC]] <del style="font-weight: bold; text-decoration: none;">resistance to fluoroquinolones is increasing</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">&lt;/div&gt;</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">&lt;div lang=&quot;en&quot; dir=&quot;ltr&quot; class=&quot;mw-content-ltr&quot;&gt;</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>'''<ins style="font-weight: bold; text-decoration: none;">Hombres</ins>'''</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>'''<del style="font-weight: bold; text-decoration: none;">Men</del>'''</div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Ciprofloxacin|<ins style="font-weight: bold; text-decoration: none;">Ciprofloxacino</ins>]] 500mg BID x10-14d, <ins style="font-weight: bold; text-decoration: none;">O</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Ciprofloxacin|<del style="font-weight: bold; text-decoration: none;">Ciprofloxacin</del>]] 500mg BID x10-14d, <del style="font-weight: bold; text-decoration: none;">OR</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Cefpodoxime|<ins style="font-weight: bold; text-decoration: none;">Cefpodoxima</ins>]] 200 mg BID x10-14d</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Cefpodoxime|<del style="font-weight: bold; text-decoration: none;">Cefpodoxime</del>]] 200 mg BID x10-14d</div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">&lt;/div&gt;</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">&lt;div lang</del>=<del style="font-weight: bold; text-decoration: none;">&quot;en&quot; dir</del>=<del style="font-weight: bold; text-decoration: none;">&quot;ltr&quot; class</del>=<del style="font-weight: bold; text-decoration: none;">&quot;mw-content-ltr&quot;&gt;</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>===<ins style="font-weight: bold; text-decoration: none;">Opciones de Internación</ins>===</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>===<del style="font-weight: bold; text-decoration: none;">Inpatient Options===</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">&lt;/div&gt;</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br/></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">&lt;div lang=&quot;en&quot; dir=&quot;ltr&quot; class=&quot;mw-content-ltr&quot;&gt;</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Ciprofloxacin|<ins style="font-weight: bold; text-decoration: none;">Ciprofloxacino</ins>]] 400mg IV q12hr, <ins style="font-weight: bold; text-decoration: none;">O</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Ciprofloxacin|<del style="font-weight: bold; text-decoration: none;">Ciprofloxacin</del>]] 400mg IV q12hr, <del style="font-weight: bold; text-decoration: none;">OR</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Ceftriaxone|<ins style="font-weight: bold; text-decoration: none;">Ceftriaxona</ins>]] 1gm IV QD, <ins style="font-weight: bold; text-decoration: none;">O</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Ceftriaxone|<del style="font-weight: bold; text-decoration: none;">Ceftriaxone</del>]] 1gm IV QD, <del style="font-weight: bold; text-decoration: none;">OR</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Cefotaxime|<ins style="font-weight: bold; text-decoration: none;">Cefotaxima</ins>]] 1-2gm IV q8hr, <ins style="font-weight: bold; text-decoration: none;">O</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Cefotaxime|<del style="font-weight: bold; text-decoration: none;">Cefotaxime</del>]] 1-2gm IV q8hr, <del style="font-weight: bold; text-decoration: none;">OR</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Gentamicin|<ins style="font-weight: bold; text-decoration: none;">Gentamicina</ins>]] 3mg/kg/<ins style="font-weight: bold; text-decoration: none;">día dividido </ins>q8hr +/- <ins style="font-weight: bold; text-decoration: none;">ampicilina </ins>1–2 gm q4hr, <ins style="font-weight: bold; text-decoration: none;">O</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Gentamicin|<del style="font-weight: bold; text-decoration: none;">Gentamicin</del>]] 3mg/kg/<del style="font-weight: bold; text-decoration: none;">day divided </del>q8hr +/- <del style="font-weight: bold; text-decoration: none;">ampicillin </del>1–2 gm q4hr, <del style="font-weight: bold; text-decoration: none;">OR</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Piperacillin/Tazobactam|<ins style="font-weight: bold; text-decoration: none;">Piperacilina</ins>/Tazobactam]] 3.375 gm IV q6hr, <ins style="font-weight: bold; text-decoration: none;">O</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Piperacillin/Tazobactam|<del style="font-weight: bold; text-decoration: none;">Piperacillin</del>/Tazobactam]] 3.375 gm IV q6hr, <del style="font-weight: bold; text-decoration: none;">OR</del></div></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Cefepime|<ins style="font-weight: bold; text-decoration: none;">Cefepima</ins>]] 2gm IV q8hr, <ins style="font-weight: bold; text-decoration: none;">O</ins></div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Cefepime|<del style="font-weight: bold; text-decoration: none;">Cefepime</del>]] 2gm IV q8hr, <del style="font-weight: bold; text-decoration: none;">OR</del></div></td><td colspan="2" class="diff-side-added"></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Imipenem|Imipenem]] 500mg IV q8hr</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>*[[Special:MyLanguage/Imipenem|Imipenem]] 500mg IV q8hr</div></td></tr> <tr><td class="diff-marker" data-marker="−"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><del style="font-weight: bold; text-decoration: none;">&lt;/div></del></div></td><td colspan="2" class="diff-side-added"></td></tr> </table> Ostermayer https://wikem.org/w/index.php?title=Template:Acute_cystitis_antibiotics/es&diff=383271&oldid=prev Ostermayer: Created page with "Template:Antibióticos para cistitis aguda" 2026-01-20T06:05:22Z <p>Created page with &quot;Template:Antibióticos para cistitis aguda&quot;</p> <p><b>New page</b></p><div>&lt;noinclude&gt;&lt;languages/&gt;&lt;/noinclude&gt;<br /> <br /> &lt;div lang=&quot;en&quot; dir=&quot;ltr&quot; class=&quot;mw-content-ltr&quot;&gt;<br /> ===Outpatient===<br /> &lt;/div&gt;<br /> <br /> &lt;div lang=&quot;en&quot; dir=&quot;ltr&quot; class=&quot;mw-content-ltr&quot;&gt;<br /> '''Women, Uncomplicated'''<br /> *[[Special:MyLanguage/Nitrofurantoin|Nitrofurantoin]] ER 100mg BID x 5d, OR<br /> *[[Special:MyLanguage/TMP/SMX|TMP/SMX]] DS (160/800mg) 1 tab BID x 3d (Females) x7days (Males), OR<br /> *[[Special:MyLanguage/Cephalexin|Cephalexin]] 250mg QID x 5d, OR<br /> *[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacin]] 250mg BID x3d<br /> **Avoid using fluoroquinolone for the first-line treatment of uncomplicated urinary tract infections (UTIs) in women.&lt;ref&gt;Choosing Wisely. American Urogynecologic Society. http://www.choosingwisely.org/societies/american-urogynecologic-society&lt;/ref&gt;<br /> *[[Special:MyLanguage/Fosfomycin|Fosfomycin]] 3 g PO once<br /> **Lower clinical and microbiologic success compared to nitrofurantoin TID for 5 days &lt;ref&gt;Huttner, A., Kowalczyk, A., Turjeman, A., Babich, T., Brossier, C., Eliakim-Raz, N., … Harbarth, S. (2018). Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial. JAMA: The Journal of the American Medical Association, 319(17), 1781–1789.&lt;/ref&gt;<br /> <br /> '''Women, Complicated'''<br /> *[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacin]] 500mg BID x10-14d, OR<br /> *[[Special:MyLanguage/Cefpodoxime|Cefpodoxime]] 200 mg BID x10-14d<br /> &lt;/div&gt;<br /> <br /> &lt;div lang=&quot;en&quot; dir=&quot;ltr&quot; class=&quot;mw-content-ltr&quot;&gt;<br /> '''Women, Concern for [[Special:MyLanguage/Urethritis|Urethritis]]'''<br /> *[[Special:MyLanguage/Ceftriaxone|Ceftriaxone]] 250mg IM x1 AND [[Special:MyLanguage/azithromycin|azithromycin]] 1gm PO x1 AND [[Special:MyLanguage/nitrofurantoin|nitrofurantoin]] ER 100mg BID x5d, OR<br /> *[[Special:MyLanguage/Levofloxacin|Levofloxacin]] 500mg QD x 14d (covers urinary pathogens, [[Special:MyLanguage/GC|GC]], and [[Special:MyLanguage/chlamydia|chlamydia]])<br /> **[[Special:MyLanguage/GC|GC]] resistance to fluoroquinolones is increasing<br /> &lt;/div&gt;<br /> <br /> &lt;div lang=&quot;en&quot; dir=&quot;ltr&quot; class=&quot;mw-content-ltr&quot;&gt;<br /> '''Men'''<br /> *[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacin]] 500mg BID x10-14d, OR<br /> *[[Special:MyLanguage/Cefpodoxime|Cefpodoxime]] 200 mg BID x10-14d<br /> &lt;/div&gt;<br /> <br /> <br /> &lt;div lang=&quot;en&quot; dir=&quot;ltr&quot; class=&quot;mw-content-ltr&quot;&gt;<br /> ===Inpatient Options===<br /> &lt;/div&gt;<br /> <br /> &lt;div lang=&quot;en&quot; dir=&quot;ltr&quot; class=&quot;mw-content-ltr&quot;&gt;<br /> *[[Special:MyLanguage/Ciprofloxacin|Ciprofloxacin]] 400mg IV q12hr, OR<br /> *[[Special:MyLanguage/Ceftriaxone|Ceftriaxone]] 1gm IV QD, OR<br /> *[[Special:MyLanguage/Cefotaxime|Cefotaxime]] 1-2gm IV q8hr, OR<br /> *[[Special:MyLanguage/Gentamicin|Gentamicin]] 3mg/kg/day divided q8hr +/- ampicillin 1–2 gm q4hr, OR<br /> *[[Special:MyLanguage/Piperacillin/Tazobactam|Piperacillin/Tazobactam]] 3.375 gm IV q6hr, OR<br /> *[[Special:MyLanguage/Cefepime|Cefepime]] 2gm IV q8hr, OR<br /> *[[Special:MyLanguage/Imipenem|Imipenem]] 500mg IV q8hr<br /> &lt;/div&gt;</div> Ostermayer